Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
PaperCitations, authors & open-access status
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,453 citations, 2020 year and bronze oa status.
1,453
Citations
2020
Year
bronze
OA Status